慢性肾脏病患者行根治性膀胱切除术及原位新膀胱术后的长期肾功能
本研究比较慢性肾脏病IIIa期患者行根治性膀胱切除术及原位新膀胱术(RC/ONB)与匹配对照的长期肾功能,共纳入508例(每组254例),中位随访3.7年。结果显示研究组51%的患者肾小球滤过率(GFR)维持或高于基线,对照组为46%(P=0.5),研究组出现显著GFR下降的平均时间更长(5.6年 vs 2年,P<0.001)。新辅助化疗是显著GFR下降及GFR低于基线的最强预测因素(HR 2.15)。作者认为IIIa期慢性肾脏病患者行ONB的长期肾功能与GFR≥60 mL/min/1.73 m2者相当,ONB是希望行可控性尿流改道者的安全选择。
要点
- IIIa期慢性肾脏病患者行ONB后51%维持或高于基线GFR,与对照组46%相比无显著差异(P=0.5)。
- 研究组出现显著GFR下降的平均时间较对照组长(5.6年 vs 2年,P<0.001)。
- 新辅助化疗是显著GFR下降(HR 2.15,95%CI 1.4-3.29)及GFR低于基线(HR 2.15,95%CI 1.4-3.29)的最强预测因素。
核心结论
- IIIa期慢性肾脏病患者行ONB的长期肾功能与GFR≥60 mL/min/1.73 m2者相当,ONB是希望行可控性尿流改道者的安全选择。
研究设计与样本
- 利用经机构审查委员会批准的机构数据库,识别行RC/ONB且GFR为45-59.9 mL/min/1.73 m2的患者,并选取GFR≥60 mL/min/1.73 m2的对照组,按年龄、基线高血压/糖尿病、围手术期化疗及术前肾积水进行匹配。
- 共纳入508例患者(每组254例),中位随访3.7年,以随访期间GFR下降>10 mL/min/1.73 m2为显著下降,采用多因素Cox回归分析各组GFR下降的预测因素。
主要发现
- 研究组术前平均GFR为53.3 mL/min/1.73 m2,对照组为78.8 mL/min/1.73 m2。
- 随访期间,研究组51%的患者GFR维持或高于基线,对照组为46%(P=0.5)。
- 研究组出现显著GFR下降的平均时间较对照组显著更长(5.6年 vs 2年,P<0.001)。
- 多因素分析中,新辅助化疗是显著GFR下降的最强预测因素(HR 2.15,95%CI 1.4-3.29,P=0.004),也是GFR低于基线的最强预测因素(HR 2.15,95%CI 1.4-3.29,P<0.001)。
临床怎么用
- 作者认为,对于希望行可控性尿流改道的IIIa期慢性肾脏病患者,ONB是安全的选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate long-term renal function in patients with chronic kidney disease (CKD) Stage IIIa who underwent radical cystectomy and orthotopic neobladder (RC/ONB) compared to matched controls. PATIENTS AND METHODS: Using our Institutional Review Board-approved institutional database, patients with a glomerular filtration rate (GFR) of 45-59.9 mL/min/1.73 m2 who underwent RC/ONB were identified. A control group of patients with a GFR of ≥60 mL/min/1.73 m2 was selected. Groups were matched based on age, baseline hypertension/diabetes mellitus, perioperative chemotherapy, and preoperative hydronephrosis. A decrease in GFR of >10 mL/min/1.73 m2 during the follow-up was considered significant. A multivariate Cox regression analysis was performed to identify predictors of GFR decline in each group. RESULTS: Of 1237 patients who underwent RC/ONB, 508 patients were included (254 per group). The mean preoperative GFR was 53.3 mL/min/1.73 m2 in the study group and 78.8 mL/min/1.73 m2 in controls. The median follow-up was 3.7 years. During follow-up, GFR stayed at or above baseline in 51% of the study patients compared to 46% of the controls (P = 0.5). The mean time to a significant GFR decline in the study patients was significantly longer compared to the controls (5.6 vs 2 years, respectively; P < 0.001). In multivariate analysis, neoadjuvant chemotherapy was found to be the strongest predictor of a significant GFR decline as well as GFR decline below baseline (hazard ratio [HR] 2.15, 95% confidence interval [CI] 1.4-3.29, P = 0.004; and HR 2.15, 95% CI 1.4-3.29, P < 0.001, respectively). CONCLUSION: Patients with CKD Stage IIIa who undergo ONB appear to have comparable long-term renal function to those with a GFR of ≥60 mL/min/1.73 m2 . An ONB reconstruction is a safe option for patients with CKD Stage IIIa desiring a continent diversion.
引用
- Ahmadi H, Reddy S, Nguyen C, et al. Long-term renal function in patients with chronic kidney disease following radical cystectomy and orthotopic neobladder. BJU Int. 2022. PMID: 35044045. doi:10.1111/bju.15685
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。